News

New FDA Drug Info Rounds Training Video Available

Topics: Fda

A new FDA Drug Info Rounds video is now available.

Read More →

FDA Reiterates Warning Against Using NuVision Pharmacy Products

Topics: Compounding and Fda

Health care providers should not use or distribute compounded drugs marketed as sterile produced by Downing Labs, LLC, of Dallas, TX, also known as NuVision Pharmacy.

Read More →

Unique Pharmaceuticals Recalls All Sterile Compounded Preparations Due to Lack of Sterility Assurance

Topics: Compounding

Unique Pharmaceuticals, Ltd, of Temple, TX, has announced a voluntary recall of all sterile drug preparations compounded by the outsourcing facility.

Read More →

FDA Approves New Abuse-Deterrent Opioid Pain Medication

Topics: Controlled substances and Fda

FDA has approved Targiniq™ ER, an opioid pain reliever designed to be more resistant to abuse.

Read More →

NIDA Announces Development of New System to Monitor Drug Abuse Trends

Topics: Prescription drug abuse

Intended to identify information that will help health experts respond quickly to potential outbreaks of illicit drug use and abuse, a new National Drug Early Warning System is under development.

Read More →

FedEx Indicted Over Role in Delivering Misbranded Prescription Drugs Ordered from Illegal Online Drug Sellers

FedEx Corporation has been indicted by a federal grand jury in San Francisco, CA,  in connection with its alleged role in trafficking controlled substances (CS) and misbranded prescription drugs for rogue online drug sellers.

Read More →

Baxter Recalls Four Lots of IV Solution Due to Particulate Matter

Baxter International Inc, of Deerfield, IL, has recalled four lots of intravenous (IV) solutions due to the presence of particulate matter. 

Read More →

Pennsylvania Task Force Releases Voluntary Opioid Prescription Guidelines

Topics: Prescription drug abuse

The Safe and Effective Prescribing Practices and Pain Management task force has created voluntary prescribing guidelines for the treatment of chronic non-cancer pain, under the direction of Governor Tom Corbett. 

Read More →

JCPP Releases New Patient-Care Document to Promote Consistency

The Joint Commission of Pharmacy Practitioners (JCPP) has released a resource document aimed at promoting consistency in the pharmacists’ process of patient care service delivery.

Read More →

White House Targets Opioids in 2014 Drug Control Strategy

Topics: Prescription drug abuse

Setting out a four-part science-based strategy for reducing illicit drug use, the White House 2014 National Drug Control Strategy includes a focus on reducing heroin and prescription painkiller abuse and overdose, which have spiked dramatically in recent years.

Read More →

New Kansas Law Allows Collaborative Practice Agreements Between Pharmacists, Physicians

Topics: Collaborative practice

Under revisions to the Kansas Pharmacy Practice Act, pharmacists may now collaborate with physicians to manage patients’ medication therapies.

Read More →